skip to main content

GLP-1 receptor agonist pancreatitis — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

HardEndocrine TherapeuticsGLP-1 receptor agonist pancreatitisGPhC CRA

A 49-year-old woman started semaglutide two months ago. She reports persistent severe abdominal pain radiating to her back with vomiting. She has lost weight and has no diarrhoea. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: DRefer urgently because pancreatitis needs assessment

GLP-1 receptor agonists can cause gastrointestinal adverse effects, but severe persistent abdominal pain radiating to the back raises concern for pancreatitis. This requires urgent clinical assessment. The medicine should not simply be continued without review.

Reference: BNF; NICE CKS